IRIS Accounts Production v25.4.0.155 06041452 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 Medium entities true false true true false false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh060414522024-03-31060414522025-03-31060414522024-04-012025-03-31060414522023-03-31060414522023-04-012024-03-31060414522024-03-3106041452ns15:EnglandWales2024-04-012025-03-3106041452ns14:PoundSterling2024-04-012025-03-3106041452ns10:Director12024-04-012025-03-3106041452ns10:Director22024-04-012025-03-3106041452ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3106041452ns10:MediumEntities2024-04-012025-03-3106041452ns10:Audited2024-04-012025-03-3106041452ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3106041452ns10:Medium-sizedCompaniesRegimeForAccounts2024-04-012025-03-3106041452ns10:FullAccounts2024-04-012025-03-310604145212024-04-012025-03-3106041452ns10:OrdinaryShareClass12024-04-012025-03-3106041452ns10:CompanySecretary12024-04-012025-03-3106041452ns10:RegisteredOffice2024-04-012025-03-3106041452ns5:CurrentFinancialInstruments2025-03-3106041452ns5:CurrentFinancialInstruments2024-03-3106041452ns5:Non-currentFinancialInstruments2025-03-3106041452ns5:Non-currentFinancialInstruments2024-03-3106041452ns5:ShareCapital2025-03-3106041452ns5:ShareCapital2024-03-3106041452ns5:RetainedEarningsAccumulatedLosses2025-03-3106041452ns5:RetainedEarningsAccumulatedLosses2024-03-3106041452ns5:ShareCapital2023-03-3106041452ns5:RetainedEarningsAccumulatedLosses2023-03-3106041452ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-3106041452ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-3106041452ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106041452ns5:PatentsTrademarksLicencesConcessionsSimilar2024-04-012025-03-3106041452ns5:LandBuildingsns5:ShortLeaseholdAssets2024-04-012025-03-3106041452ns5:PlantMachinery2024-04-012025-03-3106041452ns5:FurnitureFittings2024-04-012025-03-3106041452ns5:MotorVehicles2024-04-012025-03-3106041452ns5:ComputerEquipment2024-04-012025-03-3106041452ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-04-012025-03-3106041452ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-04-012024-03-3106041452ns5:OwnedAssets2024-04-012025-03-3106041452ns5:OwnedAssets2023-04-012024-03-3106041452ns5:LeasedAssets2024-04-012025-03-3106041452ns5:LeasedAssets2023-04-012024-03-3106041452ns5:PatentsTrademarksLicencesConcessionsSimilar2023-04-012024-03-310604145212024-04-012025-03-310604145212023-04-012024-03-3106041452ns5:HirePurchaseContracts2024-04-012025-03-3106041452ns5:HirePurchaseContracts2023-04-012024-03-3106041452ns10:OrdinaryShareClass12023-04-012024-03-3106041452ns5:PatentsTrademarksLicencesConcessionsSimilar2024-03-3106041452ns5:PatentsTrademarksLicencesConcessionsSimilar2025-03-3106041452ns5:PatentsTrademarksLicencesConcessionsSimilar2024-03-3106041452ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-3106041452ns5:PlantMachinery2024-03-3106041452ns5:FurnitureFittings2024-03-3106041452ns5:LandBuildingsns5:ShortLeaseholdAssets2025-03-3106041452ns5:PlantMachinery2025-03-3106041452ns5:FurnitureFittings2025-03-3106041452ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-3106041452ns5:PlantMachinery2024-03-3106041452ns5:FurnitureFittings2024-03-3106041452ns5:MotorVehicles2024-03-3106041452ns5:ComputerEquipment2024-03-3106041452ns5:MotorVehicles2025-03-3106041452ns5:ComputerEquipment2025-03-3106041452ns5:MotorVehicles2024-03-3106041452ns5:ComputerEquipment2024-03-3106041452ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-03-3106041452ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-03-3106041452ns5:LeasedAssetsHeldAsLessee2024-03-3106041452ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-04-012025-03-3106041452ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-04-012025-03-3106041452ns5:LeasedAssetsHeldAsLessee2024-04-012025-03-3106041452ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2025-03-3106041452ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2025-03-3106041452ns5:LeasedAssetsHeldAsLessee2025-03-3106041452ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-03-3106041452ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-03-3106041452ns5:LeasedAssetsHeldAsLessee2024-03-3106041452ns5:CostValuation2024-03-3106041452ns5:DisposalsRepaymentsInvestments2025-03-3106041452ns5:CostValuation2025-03-3106041452ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3106041452ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3106041452ns5:WithinOneYearns5:HirePurchaseContracts2025-03-3106041452ns5:WithinOneYearns5:HirePurchaseContracts2024-03-3106041452ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2025-03-3106041452ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-03-3106041452ns5:HirePurchaseContracts2025-03-3106041452ns5:HirePurchaseContracts2024-03-3106041452ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-03-3106041452ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-03-3106041452ns5:WithinOneYear2025-03-3106041452ns5:WithinOneYear2024-03-3106041452ns5:BetweenOneFiveYears2025-03-3106041452ns5:BetweenOneFiveYears2024-03-3106041452ns5:MoreThanFiveYears2025-03-3106041452ns5:MoreThanFiveYears2024-03-3106041452ns5:AllPeriods2025-03-3106041452ns5:AllPeriods2024-03-3106041452ns5:Secured2025-03-3106041452ns5:Secured2024-03-3106041452ns5:AcceleratedTaxDepreciationDeferredTax2025-03-3106041452ns5:AcceleratedTaxDepreciationDeferredTax2024-03-3106041452ns5:DeferredTaxation2024-03-3106041452ns5:DeferredTaxation2024-04-012025-03-3106041452ns5:DeferredTaxation2025-03-3106041452ns10:OrdinaryShareClass12025-03-3106041452ns5:RetainedEarningsAccumulatedLosses2024-03-31
REGISTERED NUMBER: 06041452 (England and Wales)


Cyprofood Limited

Strategic Report,

Report of the Directors and

Audited Financial Statements

for the Year Ended 31 March 2025






Cyprofood Limited (Registered number: 06041452)






Contents of the Financial Statements
for the year ended 31 March 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 5

Report of the Independent Auditors 7

Income Statement 11

Other Comprehensive Income 12

Statement of Financial Position 13

Statement of Changes in Equity 15

Notes to the Financial Statements 16


Cyprofood Limited

Company Information
for the year ended 31 March 2025







DIRECTORS: Mr S Cagin
Mr C Agcagul



SECRETARY: Mr S Cagin



REGISTERED OFFICE: Unit A1-A3,A6
Brantwood Industrial Estate
Brantwood Road
London
N17 0DX



REGISTERED NUMBER: 06041452 (England and Wales)



SENIOR STATUTORY
AUDITOR:
Altan Kemal FCA FCCA



AUDITORS: Alton & Co
Chartered Accountants
& Statutory Auditors
239-241 Kennington Lane
London
SE11 5QU

Cyprofood Limited (Registered number: 06041452)

Strategic Report
for the year ended 31 March 2025

The directors present their strategic report for the year ended 31 March 2025.

The company's performance has been in accordance with the expectations of the directors. The company has shown a high degree of resilience in a competitive industry to achieve targeted results.

REVIEW OF BUSINESS
There was a decrease in the company's turnover compared with last year. This led to a slight decrease in the net profit for the year compared with that of last year.There has been increased competition in the sector in which the company operates however the company remains resilient due to the company's performance improvement drive and increasing the product lines. Profitability over the period has been in line with expectations.The directors expect growth in sales in the coming year leading to an increase in profit in the future. Cyprofood Ltd mainly sells groceries and basic food items; the general economic fluctuations in the country do not impact much on the industry in which they operate and the main threat to the company is their competitors. The company's main strategy is to provide a complete service to customers thereby increasing their customer base and the resulting impact on the turnover. It also aims at concentrating on what it does best and ensuring that customers get the best possible service. The company aims at specific markets (and customers) to ensure that a clear strategy to win and maintain these customers are implemented and sustained.

The directors recognise the importance of all of its staff and would like to thank them for all their hard work and efforts throughout the year in helping the company make this remarkable achievement.

The results for the year and the financial position of the company are shown in the annexed financial statements.

PRINCIPAL RISKS AND UNCERTAINTIES
The company's ability to get an insurance cover is key to their ability to acquire inputs on consignment. Most of the purchases are on consignment and the consignors require an insurance cover to continue supplying on consignment. The level of cover depends on the financial health of the company.This is managed by keeping close watch on monthly results and dealing with poor performing lines on a timely basis.
Furthermore, the company's products include fresh and perishable items and stock levels for these items are low. Therefore, they depend on the reliability of the suppliers to meet their orders at short notice to prevent stock out and the resulting loss of sales and customers.
To manage this risk, the company maintains more than one supplier in order to ensure that failure of one supplier will not affect their ability to meet anticipated demand and customer satisfaction for that matter. Also new product lines are being introduced to ensure that poor performance in one line might not have a significant impact on the company.


Cyprofood Limited (Registered number: 06041452)

Strategic Report
for the year ended 31 March 2025

KEY PERFORMANCE INDICATORS
The main performance indicators are the sales and the profit margins. Most products are sold at an agreed margin thereby leading to a positive correlation between sales and profit. All other costs apart from cost of sales are fairly fixed. The directors monitor these on a monthly basis to ensure that poor performers are picked up on time and dealt with. They also ensure that other overheads are within cost limits as their effect on the ability to remain in operational existence and profitability is very critical.

The Key Performance Indicators over the last two years are as follows:

2025 2024
£    £   
Turnover 40,130 42,213
Gross Profit 7,143 8,325
Net Profit before tax &
exceptional items

1,050

1,121

The directors believe that other variables of performance indicators are marginal and are not the best indicators of the overall performance, development and position of the company.

POLICY ON PAYMENT OF CREDITORS
The policy of the company is to agree terms of payment prior to commencing trade with a supplier and to abide by those terms on a timely submission of invoices.

POLICY ON EMPLOYEES
The company is committed to achieving a working environment which provides equality of opportunity and freedom from unlawful discrimination on the basis of gender, sexual orientation, marital or civil partner status, gender reassignment, race, religion or belief, colour, nationality, ethnic or national origin, disability or age, pregnancy or maternity, trade union membership or the fact that they are part-time workers. The company's Equality and Diversity policy aims to remove unfair and discriminatory practices within the company and to encourage full contribution from its diverse community. The company is committed to actively opposing all forms of discrimination. The company also aims to provide a service that does not discriminate against its clients in the means by which they can access the services supplied by the company. The company believes that the directors, employees and customers are entitled to be treated with respect and dignity.The company's employment policy is to provide equal opportunity to all current and prospective employees without any discrimination. They endeavour to provide a work environment in which all individuals are treated with respect and dignity.

SOCIAL, ENVIRONMENT AND ETHICAL MATTERS
The company believes that by operating in an ethical and social aware manner they will help preserve the environment; that being an integral part of efficient and profitable business management. The directors recognise that success in these areas depends on the involvement and commitment of everyone in the organisation.


Cyprofood Limited (Registered number: 06041452)

Strategic Report
for the year ended 31 March 2025

FUTURE DEVELOPMENT
The directors expect a growth in sales in the future as the company explores new products and customers.

ON BEHALF OF THE BOARD:





Mr S Cagin - Director


19 December 2025

Cyprofood Limited (Registered number: 06041452)

Report of the Directors
for the year ended 31 March 2025

The directors present their report with the financial statements of the company for the year ended 31 March 2025.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of wholesale of fruit,vegetables and other groceries.

DIVIDENDS
An interim dividend of £1 per share was paid on 30 April 2024. The directors recommend that no final dividend be paid.

The total distribution of dividends for the year ended 31 March 2025 will be £ 200,000 .

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

Mr S Cagin
Mr C Agcagul

POLITICAL DONATIONS AND EXPENDITURE
Donations were non political.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Cyprofood Limited (Registered number: 06041452)

Report of the Directors
for the year ended 31 March 2025


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Alton & Co, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Mr S Cagin - Director


19 December 2025

Report of the Independent Auditors to the Members of
Cyprofood Limited

Opinion
We have audited the financial statements of Cyprofood Limited (the 'company') for the year ended 31 March 2025 which comprise the Income Statement, Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Report of the Independent Auditors to the Members of
Cyprofood Limited


Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Cyprofood Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We obtained an understanding of the legal and regulatory framework that are applicable to the company and determined that the most significant are the food standards regulation, money laundering regulation and anti bribery regulations. We understand how the company is complying with those regulations by making enquiries of management and key personel; we also reviewed correspondence files. We identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements using our general commercial and sector experience, through discussion with the directors and other management (as required by auditing standards) and from inspection of the company's regulatory and legal correspondence. We discussed with the directors and other management the policies and procedures regarding compliance with laws and regulations. We communicated those identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit.

Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the directors and other management and inspection of regulatory and legal correspondence, if any. Through these procedures, we did not become aware of actual or suspected non-compliance.

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, the further removed non-compliance with laws and regulations (irregularities) is from the events and transactions reflected in the financial statements, the less likely the inherently limited procedures required by auditing standards would identify it. In addition, as with any audit, there remained a higher risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Cyprofood Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Altan Kemal FCA FCCA (Senior Statutory Auditor)
for and on behalf of Alton & Co
Chartered Accountants
& Statutory Auditors
239-241 Kennington Lane
London
SE11 5QU

29 December 2025

Cyprofood Limited (Registered number: 06041452)

Income Statement
for the year ended 31 March 2025

2025 2024
Notes £    £   

REVENUE 40,129,895 42,212,830

Cost of sales 32,986,429 33,888,256
GROSS PROFIT 7,143,466 8,324,574

Administrative expenses 7,899,943 7,548,773
(756,477 ) 775,801

Other operating income 77,235 404,327
OPERATING (LOSS)/PROFIT 5 (679,242 ) 1,180,128


Interest payable and similar expenses 7 250,766 58,736
(LOSS)/PROFIT BEFORE TAXATION (930,008 ) 1,121,392

Tax on (loss)/profit 8 210,084 283,912
(LOSS)/PROFIT FOR THE FINANCIAL
YEAR

(1,140,092

)

837,480

Cyprofood Limited (Registered number: 06041452)

Other Comprehensive Income
for the year ended 31 March 2025

2025 2024
Notes £    £   

(LOSS)/PROFIT FOR THE YEAR (1,140,092 ) 837,480


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE
(LOSS)/INCOME FOR THE YEAR

(1,140,092

)

837,480

Cyprofood Limited (Registered number: 06041452)

Statement of Financial Position
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 10 111 148
Property, plant and equipment 11 645,508 845,056
Investments 12 - 1,000
645,619 846,204

CURRENT ASSETS
Inventories 13 3,959,618 3,877,273
Debtors 14 2,255,982 8,418,501
Cash at bank and in hand 3,615,986 2,854,403
9,831,586 15,150,177
CREDITORS
Amounts falling due within one year 15 5,868,031 9,865,845
NET CURRENT ASSETS 3,963,555 5,284,332
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,609,174

6,130,536

CREDITORS
Amounts falling due after more than one
year

16

(183,886

)

(318,452

)

PROVISIONS FOR LIABILITIES 20 (148,022 ) (194,726 )
NET ASSETS 4,277,266 5,617,358

Cyprofood Limited (Registered number: 06041452)

Statement of Financial Position - continued
31 March 2025

2025 2024
Notes £    £    £    £   
CAPITAL AND RESERVES
Called up share capital 21 200,000 200,000
Retained earnings 22 4,077,266 5,417,358
SHAREHOLDERS' FUNDS 4,277,266 5,617,358


The financial statements were approved by the Board of Directors and authorised for issue on 19 December 2025 and were signed on its behalf by:




Mr S Cagin - Director



Mr C Agcagul - Director


Cyprofood Limited (Registered number: 06041452)

Statement of Changes in Equity
for the year ended 31 March 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 April 2023 200,000 4,579,878 4,779,878

Changes in equity
Total comprehensive income - 837,480 837,480
Balance at 31 March 2024 200,000 5,417,358 5,617,358

Changes in equity
Dividends - (200,000 ) (200,000 )
Total comprehensive loss - (1,140,092 ) (1,140,092 )
Balance at 31 March 2025 200,000 4,077,266 4,277,266

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements
for the year ended 31 March 2025

1. STATUTORY INFORMATION

Cyprofood Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial Reporting Standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

the requirements of Section 7 Statement of Cash Flows.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.
Masca Holdings Limited is the parent company of the group and copies of the consolidated accounts can be obtained from Unit 2, The Britannia Centre, Lenthall Road, Loughton, IG10 3SQ.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is recognised when the customer takes delivery of the goods and is derived from the ordinary activities of the business. All turnover are derived from sales in the UK.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Short leasehold - straight line over the life of the lease
Plant and machinery - 25% on reducing balance
FF & equipment - 25% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is determined on a first in first out basis. Net realisable value is the selling price less any direct cost to sell.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Consignment purchases
Goods acquired on consignment are not recognised as the company's purchases until the title of the goods changes to the company; this occurs when the goods are sold.

3. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 2,130,301 2,948,590
Social security costs 187,679 271,359
Other pension costs 17,218 70,719
2,335,198 3,290,668

The average number of employees during the year was as follows:
2025 2024

Directors 2 2
Administration & finance 6 2
Operations 76 91
84 95

4. DIRECTORS' EMOLUMENTS
2025 2024
£    £   
Directors' remuneration - -

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

5. OPERATING (LOSS)/PROFIT

The operating loss (2024 - operating profit) is stated after charging/(crediting):

2025 2024
£    £   
Hire of plant and machinery 288,569 242,838
Leasing of motor vehicle 1,232,126 1,547,606
Depreciation - owned assets 118,362 273,538
Depreciation - assets on hire purchase contracts 95,926 5,597
Loss on disposal of fixed assets 945 -
Patents and licences amortisation 37 37
Auditors' remuneration 22,000 19,000
Taxation advisory services 6,800 1,000
Other non- audit services 20,900 21,630
Foreign exchange differences 24 (6,626 )

6. EXCEPTIONAL ITEMS
2025 2024
£    £   
Inter co balances written off (1,980,100 ) -

7. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank interest 212,099 -
Bank loan interest - 30,000
Interest and penalties 16,417 7,590
Hire purchase interest 22,250 21,146
250,766 58,736

8. TAXATION

Analysis of the tax charge
The tax charge on the loss for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 256,788 297,068

Deferred tax provision (46,704 ) (13,156 )
Tax on (loss)/profit 210,084 283,912

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

8. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
(Loss)/profit before tax (930,008 ) 1,121,392
(Loss)/profit multiplied by the standard rate of corporation tax in the
UK of 25% (2024 - 25%)

(232,502

)

280,348

Effects of:
Expenses not deductible for tax purposes 4,341 2,303
Depreciation in excess of capital allowances 1,233 1,261
adjustment
Group loss utilized (58,013 ) -

Inter company balances w/o 495,025 -
Total tax charge 210,084 283,912

9. DIVIDENDS
2025 2024
£    £   
Ordinary shares of £1 each
Interim 200,000 -

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

10. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 April 2024
and 31 March 2025 370
AMORTISATION
At 1 April 2024 222
Amortisation for year 37
At 31 March 2025 259
NET BOOK VALUE
At 31 March 2025 111
At 31 March 2024 148

11. PROPERTY, PLANT AND EQUIPMENT
Short Plant and FF &
leasehold machinery equipment
£    £    £   
COST
At 1 April 2024 50,455 1,218,977 509,511
Additions - - -
At 31 March 2025 50,455 1,218,977 509,511
DEPRECIATION
At 1 April 2024 27,635 738,345 264,344
Charge for year 5,045 120,158 61,292
At 31 March 2025 32,680 858,503 325,636
NET BOOK VALUE
At 31 March 2025 17,775 360,474 183,875
At 31 March 2024 22,820 480,632 245,167

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

11. PROPERTY, PLANT AND EQUIPMENT - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 April 2024 73,637 124,202 1,976,782
Additions - 14,740 14,740
At 31 March 2025 73,637 138,942 1,991,522
DEPRECIATION
At 1 April 2024 47,725 53,677 1,131,726
Charge for year 6,477 21,316 214,288
At 31 March 2025 54,202 74,993 1,346,014
NET BOOK VALUE
At 31 March 2025 19,435 63,949 645,508
At 31 March 2024 25,912 70,525 845,056

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and Motor
machinery vehicles Totals
£    £    £   
COST
At 1 April 2024
and 31 March 2025 652,293 22,387 674,680
DEPRECIATION
At 1 April 2024 285,378 5,597 290,975
Charge for year 91,729 4,197 95,926
At 31 March 2025 377,107 9,794 386,901
NET BOOK VALUE
At 31 March 2025 275,186 12,593 287,779
At 31 March 2024 366,915 16,790 383,705

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

12. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 April 2024 1,000
Disposals (1,000 )
At 31 March 2025 -
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 1,000

13. INVENTORIES
2025 2024
£    £   
Finished goods 3,959,618 3,877,273

14. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 1,403,433 3,032,603
Purchase ledger debit balances 447,017 70,075
Rent deposit 110,682 110,682
Amounts owed by group undertakings - 4,654,455
VAT 126,783 156,429
Prepayments 168,067 394,257
2,255,982 8,418,501

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

15. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 17) 2,826,350 2,998,425
Hire purchase contracts (see note 18) 134,566 134,566
Trade creditors 1,959,919 4,799,612
Sales ledger credit bal 59,625 6,674
Amounts owed to group undertakings - 1,538,247
Corporation tax payable 535,531 297,068
Social security and other taxes 302,480 61,314
Pension control 1,443 6,439
Accrued expenses 48,117 23,500
5,868,031 9,865,845

16. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
2025 2024
£    £   
Hire purchase contracts (see note 18) 183,886 318,452

17. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts 2,826,350 2,998,425

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

18. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2025 2024
£    £   
Gross obligations repayable:
Within one year 156,816 156,816
Between one and five years 213,111 369,927
369,927 526,743

Finance charges repayable:
Within one year 22,250 22,250
Between one and five years 29,225 51,475
51,475 73,725

Net obligations repayable:
Within one year 134,566 134,566
Between one and five years 183,886 318,452
318,452 453,018

Non-cancellable
operating leases
2025 2024
£    £   
Within one year 639,687 627,281
Between one and five years 1,852,039 2,242,725
In more than five years - 249,000
2,491,726 3,119,006

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

19. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£    £   
Bank overdrafts 2,826,350 2,998,425

Bank overdraft are secured by way of a fixed and floating charge over the assets of the company and a cross guarantee on all the assets of Masca holding Limited and its subsidiaries.

20. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax
Accelerated capital allowances 148,022 194,726

Deferred
tax
£   
Balance at 1 April 2024 194,726
Credit to Income Statement during year (46,704 )
Excess capital allowance
Balance at 31 March 2025 148,022

21. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
200,000 Ordinary £1 200,000 200,000

22. RESERVES
Retained
earnings
£   

At 1 April 2024 5,417,358
Deficit for the year (1,140,092 )
Dividends (200,000 )
At 31 March 2025 4,077,266

Cyprofood Limited (Registered number: 06041452)

Notes to the Financial Statements - continued
for the year ended 31 March 2025

23. ULTIMATE PARENT COMPANY

Masca Holdings Limited is regarded by the directors as being the company's ultimate parent company.

24. CONTINGENT LIABILITIES

All companies in the group have provided a cross guarantee to The Care Home Lender for a loan taken out in August 2025 to replace the loan existing at the year end. The balance at the year end was £10,665,964 (2024 - £11,658,160).